CROSSJECT

XPAR:ALCJ (France)  
€ 2.02 (+0.5%) Apr 26
At Loss
Market Cap:
€ 73.98M ($ 79.32M)
Enterprise V:
€ 90.37M ($ 96.88M)
Volume:
57.01K
Avg Vol (2M):
99.01K
Also Trade In:

Business Description

Description
CROSSJECT manufactures and markets needle-free drug self-injection system.
Name Current Vs Industry Vs History
Cash-To-Debt 0.25
Equity-to-Asset -0.04
Debt-to-Equity -18.25
Debt-to-EBITDA -3.99
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -0.38
Distress
Grey
Safe
Beneish M-Score -2.87
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 36.09
9-Day RSI 33.24
14-Day RSI 31.46
6-1 Month Momentum % -21.71
12-1 Month Momentum % -18.98

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.66
Quick Ratio 2.15
Cash Ratio 1.04
Days Inventory 258.47
Days Sales Outstanding 2149.61
Days Payable 363.43

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -21.4
Shareholder Yield % -6.08

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % -488.4
Operating Margin % -2555.6
Net Margin % -1968.8
FCF Margin % -2869.6
ROE % -638.25
ROA % -31.27
ROIC % -48.6
ROC (Joel Greenblatt) % -131.35
ROCE % -45.36

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 144.29
EV-to-EBIT -7.41
EV-to-EBITDA -16.56
EV-to-Revenue 180.73
EV-to-FCF -6.3
Earnings Yield (Greenblatt) % -13.5
FCF Yield % -19.39